Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 24Unknown 16Recruiting 5Not yet recruiting 4Terminated 2Withdrawn 1

Sponsor Class

OTHER 61INDUSTRY 9NIH 5NETWORK 3OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 11Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Vomiting 1Ulcer 1Stomatitis 1Skin Cancer Face 1Recurrence 1Pathologic Complete Response 1Parasomnias 1Pain, Intractable 1Ovarian Neoplasms 1Opportunistic Infections 1Neoplasm Metastasis 1Nausea 1Melanoma 1Medulloblastoma 1Lung Neoplasms 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Kidney Neoplasms 1Inflammation 1Hepatitis C, Chronic 1Hepatitis C 1Hematologic Neoplasms 1Glioblastoma 1Fatigue 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × OTHER_GOV × Colonic Neoplasms × Clear all
NCT04270461 2020-10-22

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Jiujiang University Affiliated Hospital

Phase 1 Withdrawn
CNSGastrointestinal

Colonic Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡